Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center

Neurology. 2005 Feb 8;64(3):494-500. doi: 10.1212/01.WNL.0000150886.50187.30.

Abstract

Background: Epidemiologic studies have implicated cerebrovascular disease and its antecedents as risk factors for Alzheimer disease (AD). Cerebral atherosclerosis or strokes may increase the deposition of neuritic plaques or the formation of neurofibrillary tangles. Alternatively, they may simply hasten the age at onset of disease, or increase the severity of disease symptoms. This investigation examined the association between cerebrovascular disease and the pathologic manifestations of AD in an autopsy series.

Methods: This was a cross-sectional study using data from the United States National Alzheimer's Coordinating Center database. The primary analysis included 1,054 individuals with clinical information and semiquantitative neuropathologic measurements: 921 had AD as the primary neuropathologic diagnosis and 133 were considered neuropathologically normal.

Results: Overall, 9% of the individuals had clinical history of stroke during life, but 33% had evidence of cerebral infarcts at postmortem. There was no association between neuritic plaques or neurofibrillary tangles, the primary neuropathologic manifestations of AD, with either clinical history of stroke or the presence of cerebral infarcts at postmortem. The authors did find a higher frequency of neuritic plaques and neurofibrillary tangles with increased amyloid angiopathy. Neither plaques nor tangles were associated with small vessel cerebrovascular disease, arteriosclerosis. However, the presence of large-vessel cerebrovascular disease, or atherosclerosis, was strongly associated with an increased frequency of neuritic plaques.

Conclusions: Atherosclerotic cerebrovascular disease may have a role in the pathogenesis of Alzheimer disease, because of a strong association with frequent neuritic plaques.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / epidemiology*
  • Alzheimer Disease / etiology
  • Alzheimer Disease / genetics
  • Alzheimer Disease / pathology
  • Apolipoprotein E4
  • Apolipoproteins E / genetics
  • Cerebral Amyloid Angiopathy / complications
  • Cerebral Amyloid Angiopathy / epidemiology
  • Cerebral Amyloid Angiopathy / pathology
  • Cerebral Infarction / complications
  • Cerebral Infarction / epidemiology
  • Cerebral Infarction / pathology
  • Comorbidity
  • Cross-Sectional Studies
  • Databases, Factual
  • Dementia, Vascular / epidemiology*
  • Dementia, Vascular / etiology
  • Dementia, Vascular / pathology
  • Female
  • Humans
  • Intracranial Arteriosclerosis / complications
  • Intracranial Arteriosclerosis / epidemiology*
  • Intracranial Arteriosclerosis / pathology
  • Male
  • Neurofibrillary Tangles*
  • Plaque, Amyloid*
  • Risk Factors
  • United States / epidemiology

Substances

  • Apolipoprotein E4
  • Apolipoproteins E